Sionna Therapeutics, Inc. (SION)

NASDAQ: SION · Real-Time Price · USD

49.94

+0.68 (1.38%)

Aug 4, 2026, 4:00 PM EDT - Market closed

Sionna Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	63.32	58.45	37.79	38.52	54.84
Short-Term Investments	152.83	177.43	109.75	-	27.77
Cash & Short-Term Investments	216.15	235.88	147.54	38.52	82.61
Cash Growth	-19.84%	59.88%	283.01%	-53.37%	-
Other Current Assets	4.81	5.54	3.46	0.69	1.22
Total Current Assets	220.96	241.42	150.99	39.21	83.83
Net Property, Plant & Equipment	8.75	9.15	10.3	11.73	2.57
Long-Term Investments	73.78	74.42	20.51	-	-
Other Long-Term Assets	1.55	0.96	3.96	1.01	1.01
Total Assets	305.04	325.95	185.75	51.95	87.37

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	2.11	0.77	1.19	0.72	0.56
Accrued Expenses	6.35	9.67	8.16	6.59	7.7
Current Portion of Leases	1.32	1.27	1.07	0.73	-
Total Current Liabilities	9.78	11.71	10.42	8.04	8.25
Long-Term Leases	7.06	7.41	8.68	9.75	-
Total Long-Term Liabilities	7.06	7.41	8.68	9.75	-
Total Liabilities	16.83	19.12	19.1	17.79	8.25

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	0.05	0.05	0.01	0	0
Additional Paid-in Capital	571.38	562.6	17	4.52	2.23
Accumulated Other Comprehensive Income	-0.08	0.54	0.37	-	-0.02
Retained Earnings	-283.13	-256.35	-181.09	-119.4	-72.14
Total Common Shareholders' Equity	288.21	306.83	-163.71	-114.88	-69.92
Minority Interest	-	-	330.37	149.04	149.04
Shareholders' Equity	288.21	306.83	166.66	34.16	79.12
Total Liabilities & Equity	305.04	325.95	185.75	51.95	87.37

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	8.38	8.68	9.75	10.48	0
Net Cash (Debt)	207.77	227.21	137.79	28.04	82.61
Net Cash Growth	-20.14%	64.89%	391.33%	-66.05%	-
Net Cash Per Share	4.67	5.69	35.71	9.56	0.03
Book Value	288.21	306.83	-163.71	-114.88	-69.92
Book Value Per Share	6.48	7.68	-42.43	-39.17	-0.03
Tangible Book Value	288.21	306.83	-163.71	-114.88	-69.92
Tangible Book Value Per Share	6.48	7.68	-42.43	-39.17	-0.03

SEC Filings: 10-K · 10-Q